Experience

Recent Therapeutic experience:

• Pulmonary: bronchiectasis, COPD, pulmonary arterial hypertension (PAH)

• Oncology: advanced NSCLC with EGFR mutations, prostate cancer, AML, CML 

• Immunology: RA, Crohn’s disease, Ulcerative Colitis

• Rare disease: NTM lung disease, primary biliary cholangitis (PBC liver), narcolepsy

Most recent projects:

• Executed research exploring HCP /patient disconnects to drive disease state awareness activities

• Tested promotional creative territories with HCPs and Patients using behavioral science

• Provided critical customer feedback to guide company-wide strategic response to a new MOA threatening to disrupt treatment paradigm

• Pricing research in breakthrough oncologic therapies, both US and globally

• Prioritized a range of indications for early pipeline asset assessing market potential and clinical endpoints

• Implemented Global Competitive Intelligence capability to proactively plan and mitigate for competitor activity